HASTINGS DAVID C
Insider CIK 1237401 · SCYX Director · ABUS Chief Financial Officer · UNIS See Remarks · TRVI Chief Financial Officer · ETTX Director · INCY Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCYX SCYNEXIS INC | A Award deriv | 2026-06-26 | 2026-06-30 | 2,875 | — | $0 | 2,875 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2026-06-26 | 2026-06-30 | 2,875 | — | $0 | 11,522 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-01-08 | 2026-01-12 | 375,000 | — | $0 | 375,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 69,183 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2025-02-14 | 2025-02-19 | 365,800 | — | $0 | 365,800 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award | 2025-02-14 | 2025-02-19 | 90,100 | — | $0 | 249,824 | SEC↗ |
| ABUS Arbutus Biopharma Corp | S Sale | 2025-02-04 | 2025-02-05 | 22,183 | $3.28 | $72.8K | 159,724 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 46,183 | SEC↗ |
| ABUS Arbutus Biopharma Corp | S Sale | 2024-02-02 | 2024-02-05 | 9,593 | $2.31 | $22.2K | 181,907 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2024-02-01 | 2024-02-05 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award | 2024-02-01 | 2024-02-05 | 112,500 | — | $0 | 191,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2023-06-15 | 2023-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2023-06-15 | 2023-06-23 | 10,000 | — | $0 | 23,183 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2023-02-01 | 2023-02-03 | 316,000 | — | $0 | 316,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award | 2023-02-01 | 2023-02-03 | 79,000 | — | $0 | 79,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 11,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 26,583 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer | 2022-07-11 | 2022-07-11 | 27,500 | $2.20 | $60.5K | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | U Tender | 2022-07-07 | 2022-07-11 | 22,000 | $2.20 | $48.4K | 0 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 13,183 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2022-01-20 | 2022-01-20 | 285,000 | $2.81 | $800.9K | 285,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2022-01-18 | 2022-01-19 | 27,500 | — | $0 | 49,500 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 7,500 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 5,769 | — | $0 | 5,769 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 12,060 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 9,276 | — | $0 | 9,276 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 15,000 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2021-06-16 | 2021-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2021-04-01 | 2021-04-02 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2021-02-13 | 2021-02-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2021-03-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2020-07-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2020-06-10 | 2020-10-06 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2020-02-17 | 2020-02-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-06-19 | 2019-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-06-18 | 2019-06-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2019-03-01 | 2019-03-05 | 137,500 | — | $0 | 137,500 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-01-18 | 2019-01-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-01-02 | 2019-01-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2018-06-19 | 2018-06-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy deriv | 2018-03-08 | 2018-03-12 | 8,875 | — | $0 | 8,875 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy deriv | 2018-03-08 | 2018-03-12 | 5,325 | — | $0 | 5,325 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2018-03-08 | 2018-03-12 | 11,834 | $1.69 | $20.0K | 31,834 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-01-02 | 2018-01-04 | 19,989 | — | $0 | 19,989 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2017-06-21 | 2017-06-22 | 20,000 | $1.75 | $35.0K | 20,000 | SEC↗ |
| UNIS Unilife Corp | A Award deriv | 2017-01-26 | 2017-01-30 | 150,000 | — | $0 | 150,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-03 | 2017-01-05 | 14,499 | — | $0 | 14,499 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-06-02 | 2016-06-06 | 8,800 | $3.98 | $35.0K | 8,800 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-09-24 | 2015-09-28 | 11,700 | — | $0 | 11,700 | SEC↗ |
| UNIS Unilife Corp | A Award | 2015-02-23 | 2015-02-25 | 300,000 | — | $0 | 300,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-05 | 2014-06-06 | 50,000 | — | $0 | 33,375 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-05 | 2014-06-06 | 23,966 | — | $0 | 30,430 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-05 | 2014-06-06 | 50,000 | — | $0 | 36,469 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-06-05 | 2014-06-06 | 123,966 | $52.81 | $6.55M | 8,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-05 | 2014-06-06 | 50,000 | $5.46 | $273.0K | 132,466 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-05 | 2014-06-06 | 50,000 | $3.11 | $155.5K | 82,466 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-05 | 2014-06-06 | 23,966 | $9.41 | $225.5K | 32,466 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-04 | 2014-06-06 | 18,534 | — | $0 | 54,396 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-04 | 2014-06-06 | 6,500 | — | $0 | 21,400 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-04 | 2014-06-06 | 43,500 | — | $0 | 35,817 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-04 | 2014-06-06 | 7,500 | — | $0 | 7,083 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-04 | 2014-06-06 | 6,500 | $17.79 | $115.6K | 15,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-04 | 2014-06-06 | 18,534 | $9.41 | $174.4K | 84,534 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-04 | 2014-06-06 | 7,500 | $13.34 | $100.0K | 66,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-04 | 2014-06-06 | 43,500 | $14.72 | $640.3K | 58,500 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-06-04 | 2014-06-06 | 76,034 | $52.61 | $4.00M | 8,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-18 | 2014-02-18 | 32,001 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-18 | 2014-02-18 | 32,001 | $8.99 | $287.7K | 40,501 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-18 | 2014-02-18 | 32,001 | $65.64 | $2.10M | 8,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-14 | 2014-02-18 | 34,964 | — | $0 | 32,001 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-14 | 2014-02-18 | 5,036 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-14 | 2014-02-18 | 34,964 | $8.99 | $314.3K | 43,464 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-14 | 2014-02-18 | 5,036 | $8.99 | $45.3K | 48,500 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-14 | 2014-02-18 | 40,000 | $64.74 | $2.59M | 8,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 7,999 | — | $0 | 5,036 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 9,665 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 13,000 | — | $0 | 79,317 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 16,000 | — | $0 | 28,462 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 90,335 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 66,000 | — | $0 | 27,900 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 9,665 | $11.98 | $115.8K | 26,164 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 7,999 | $8.99 | $71.9K | 16,499 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 13,000 | $14.72 | $191.4K | 39,164 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 16,000 | $18.32 | $293.1K | 55,164 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 90,335 | $11.98 | $1.08M | 145,499 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 66,000 | $17.79 | $1.17M | 211,499 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-13 | 2014-02-18 | 202,999 | $66.12 | $13.42M | 8,500 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-01-21 | 2014-01-23 | 1,450 | — | $0 | 1,450 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-01-21 | 2014-01-23 | 23,379 | — | $0 | 23,379 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-09-06 | 2013-09-09 | 5,556 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-09-06 | 2013-09-09 | 94,444 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2013-09-06 | 2013-09-09 | 100,000 | $35.16 | $3.52M | 8,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-09-06 | 2013-09-09 | 5,556 | $7.09 | $39.4K | 108,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-09-06 | 2013-09-09 | 94,444 | $7.09 | $669.6K | 102,944 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-02-15 | 2013-02-20 | 60,000 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-02-15 | 2013-02-20 | 30,000 | — | $0 | 66,965 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-02-15 | 2013-02-20 | 417 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-02-15 | 2013-02-20 | 9,583 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-02-15 | 2013-02-20 | 9,583 | $8.19 | $78.5K | 18,083 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-02-15 | 2013-02-20 | 417 | $8.19 | $3.4K | 18,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-02-15 | 2013-02-20 | 30,000 | $8.99 | $269.7K | 48,500 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2013-02-15 | 2013-02-20 | 100,000 | $22.52 | $2.25M | 8,500 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-02-15 | 2013-02-20 | 60,000 | $5.12 | $307.2K | 108,500 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2013-02-09 | 2013-02-12 | 44,462 | — | $0 | 44,462 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2013-02-09 | 2013-02-12 | 5,538 | — | $0 | 5,538 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2012-01-19 | 2012-01-23 | 93,900 | — | $0 | 93,900 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2012-01-19 | 2012-01-23 | 6,100 | — | $0 | 6,100 | SEC↗ |